文献速递颈动脉与弓上血管

80岁及以上无症状对侧颈动脉闭塞患者的手术干预应选择性开展

Surgical intervention among asymptomatic patients aged ≥80 with a contralateral carotid occlusion appears selectively warranted.
PubMed 文献 · J Vasc Surg · 2025-08-05

基于血管质量倡议数据库分析3486例对侧颈动脉闭塞的无症状颈动脉手术患者,14.7%年龄≥80岁。倾向性匹配后,≥80岁与<80岁患者30天卒中/死亡复合终点及5年生存率相似,但两组围术期复合事件率均超过SVS 3%安全基准,提示高龄患者应选择性手术。

要点

  • ≥80岁对侧颈动脉闭塞的无症状患者围术期卒中/死亡风险与年轻患者相当。
  • 两组30天卒中/死亡复合率均超过SVS 3%安全基准,需谨慎选择患者。
  • 对高龄高危患者,颈动脉干预应基于个体化评估选择性实施。

核心结论

  • ≥80岁对侧ICA闭塞的无症状患者围术期结局与<80岁患者相似,支持在卒中风险升高的合适老年患者中考虑手术。
  • 但两组围术期卒中/死亡复合率均超过SVS 3%安全基准,因此≥80岁患者应选择性干预。

研究设计与样本

  • 回顾性队列分析血管质量倡议数据库,纳入3486例对侧颈动脉闭塞的无症状颈动脉手术患者(CEA 72.0%,TCAR 28.0%)。
  • 主要暴露为年龄(<80岁 vs ≥80岁),主要结局为30天卒中、30天死亡和5年生存,采用logistic回归、Cox回归和倾向性评分匹配进行风险调整。

主要发现

  • ≥80岁患者占14.7%,女性29.5%,白人91.1%;≥80岁患者更常接受TCAR(<80岁26.7% vs ≥80岁35.2%)。
  • 未调整30天卒中风险<80岁2.2% vs ≥80岁1.0%(P = .26),30天死亡率<80岁0.9% vs ≥80岁2.3%(P = .04)。
  • 未调整30天卒中或死亡风险<80岁2.9% vs ≥80岁4.0%(P = .34)。
  • 倾向性匹配511对后,卒中或死亡复合终点<80岁4.6% vs ≥80岁4.0%(P = .73)。
  • 18个月无卒中生存率<80岁81.2%(95%CI 76%-87%) vs ≥80岁78.0%(95%CI 73%-84%)(log-rank P = .4);5年生存率<80岁84.6%(95%CI 80.2%-89.3%) vs ≥80岁80.8%(95%CI 76.2%-85.8%)(log-rank P = .4)。

关键数值与推荐

  • 无症状患者颈动脉手术的SVS安全基准为3%,本研究中<80岁和≥80岁患者围术期卒中或死亡复合率分别为2.9%和4.0%(未调整)。

临床怎么用

  • 对≥80岁对侧颈动脉闭塞的无症状患者,应个体化评估卒中风险与手术获益,选择性行颈动脉血运重建。
  • 鉴于围术期风险可能超过SVS 3%基准,需加强患者选择和围术期管理。

局限性

  • 回顾性数据库分析可能存在选择偏倚和未测量混杂。
  • 原文未报告其他局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The role of prophylactic carotid revascularization in asymptomatic patients aged ≥80 remains controversial. Current guidelines stipulate that asymptomatic older patients at "higher risk of stroke" on best medical therapy may still benefit from carotid intervention. Specifically, there is a widespread perception that a contralateral internal carotid artery (ICA) occlusion may confer an increased anatomical stroke risk, thus creating a surgical dilemma, particularly among older patients. The purpose of this analysis was to determine whether asymptomatic patients aged ≥80 years derive a stroke or survival benefit from prophylactic carotid revascularization in the setting of a contralateral internal carotid artery occlusion. METHODS: We analyzed asymptomatic patients with a contralateral occlusion who underwent carotid endarterectomy or transcarotid artery revascularization (TCAR) using the Vascular Quality Initiative database. Our primary exposure was age (<80 years vs ≥ 80 years). Primary outcomes included 30-day stroke, 30-day mortality, and 5-year survival. Logistic regression, Cox regression, and propensity score matching were used for risk adjustment. RESULTS: We identified a total of 3486 asymptomatic patients who underwent carotid surgery (carotid endarterectomy, 72.0%; TCAR, 28.0%) in the setting of a contralateral carotid occlusion, 14.7% were aged ≥80 years, 29.5% were female, and 91.1% were White. Older patients had overall similar comorbidities compared with younger patients, but were more likely to undergo TCAR (<80 years, 26.7% vs ≥ 80 years, 35.2%). The unadjusted 30-day stroke risk was similar between age groups (<80 years 2.2%, vs ≥80 years, 1.0%; P = .26); however, mortality was two-fold higher among patients aged ≥80 years (<80 years, 0.9% vs ≥ 80 years, 2.3%; P = .04). The unadjusted risk of 30-day stroke or death was 2.9% for patients aged <80 years and 4.0% for those ≥80 years (P = .34). Propensity score matching yielded 511 matched pairs. The composite end point of stroke or death in the matched cohort was 4.6% for patients <80 years and 4.0% for those ≥80 years (P = .73). The 18-month stroke-free survival was 81.2% (95% confidence interval [CI], 76%-87%) in patients <80 years and 78.0% (95% CI, 73%-84%) in those ≥80-years (log-rank P value = .4;). The 5-year survival rates was similar between groups (<80 years, 84.6% [95% CI, 80.2%-89.3%], ≥80 years, 80.8% [95% CI, 76.2%-85.8%]; log-rank P = .4). CONCLUSIONS: Perioperative outcomes in asymptomatic patients aged ≥80 years with a contralateral ICA occlusion were similar to those in patients aged <80 years, validating the rationale to consider surgery in eligible older patients at elevated stroke risk. Notably, both younger and older patients experienced composite perioperative stroke or death rates exceeding the current Society for Vascular Surgery safety benchmark of 3% in asymptomatic patients. Therefore, based on these results, carotid intervention should be selectively applied in patients aged ≥80 years within this high-risk subgroup.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Eid MA, Columbo JA, Perry I, et al. Surgical intervention among asymptomatic patients aged ≥80 with a contralateral carotid occlusion appears selectively warranted. J Vasc Surg. 2025. PMID: 40769462. doi:10.1016/j.jvs.2025.07.051

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。